Thursday's Health Winners & Losers

Bradley Pharmaceuticals falls.
Author:
Publish date:

Bradley Pharmaceuticals

(BDY)

tumbled after the biotech company's fourth-quarter profit fell short of Wall Street's expectations. The stock was losing $2.46, or 12.3%, to $17.48.

On the other hand,

Bayer AG

reported a fourth-quarter profit that exceeded expectations. The German drugmaker was recently up $1.15, or 2%, to $58.32.

Caremark

(CMX)

rose 1.3% after

CVS

(CVS) - Get Report

shareholders voted to approve the pending merger deal. CVS will acquire Caremark for $26.5 billion in cash and stock. CVS was also higher, adding 45 cents, or 1.4%, to $32.76.

Express Scripts

(ESRX)

, which had launched its own hostile bid for Caremark before getting rejected, was shedding 45 cents, or 0.6%, at $80.65.

Elsewhere,

MedImmune

(MEDI)

was gaining 1.5% at $31.35.

Coventry Health Care

(CVH)

was tacking on 1.2% at $55.

Laboratory Corp. of America Holdings

(LH) - Get Report

was recently up 1.2% to $71.06.

Among decliners,

Celgene

(CELG) - Get Report

was losing 2.5% at $50.86.

St. Jude Medical

(STJ)

was recently lower by 2.4% at $37.58.

Amgen

(AMGN) - Get Report

was off 1% to $60.11.